Pasithea Therapeutics Corp. · NASDAQ:KTTA
Vivo Opportunity Fund Holdings, L.P. reported a 9.99% stake in Pasithea Therapeutics Corp. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Vivo Opportunity Fund Holdings, L.P. reported a 9.99% stake in Pasithea Therapeutics Corp., 9,286,738 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 9,286,738
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 9.99% | 9,286,738 |
| Vivo Opportunity, LLC | 9.99% | 9,286,738 |
| Vivo Opportunity Cayman Fund, L.P. | 9.99% | 937,567 |
| Vivo Opportunity Cayman, LLC | 9.99% | 937,567 |
Source
Related
- Pasithea Therapeutics Corp.
- Vivo Opportunity, LLC
- Pasithea Therapeutics Corp. shareholders
- Schedule 13G · Vivo Opportunity, LLC · Dec 5, 2025
- Schedule 13G/A · Opaleye Management Inc. · Jul 31, 2026
- Schedule 13G/A · Coastlands Capital LP · Jul 1, 2026
- Schedule 13G · Stonepine Capital Management, LLC · Jun 23, 2026
- Form 4 · Coastlands Capital LP · Jun 22, 2026
- Schedule 13G/A · Ameriprise Financial Inc · May 15, 2026